FDA Warns Pharmacies Against Unauthorized Weight-Loss Drug Replications
Federal regulators have launched an enforcement campaign against pharmaceutical compounding operations for manufacturing unauthorized generic versions of blockbuster weight-loss medications in violation of patent laws.